Abstract

Reducing Kidney Disease Burden in Type 2 Diabetes with SGLT2 Inhibitors: Shifting the Goalposts Upstream.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call